A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors

Human Gene Therapy

Volumn 7, Issue 16, 1996, Pages 2003-2013

  Pechan, Peter A ^a   Fotaki, Maria ^b,d   Thompson, Richard L ^c   Dunn, Rob ^b   Chase, Maureen ^a   Chiocca, E Antonio ^a   Breakefield, Xandra O ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF CINCINNATI   (United States)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE TARGETING; GLIOMA; HELPER VIRUS; HERPES SIMPLEX VIRUS 1; MARKER GENE; NONHUMAN; RAT; VERO CELL; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALIA; ESCHERICHIA COLI; HERPES; HUMAN HERPESVIRUS 1; RODENTIA; SIMPLEXVIRUS;

EID: 0029838241     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.16-2003     Document Type: Article

References (39)

1. BERTHOMME, H., FOURNEL, S., and EPSTEIN, A.L. (1996). Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals. Virology 216, 437-443.
2. BOVIATSIS, E.J., PARK, S., SENA-ESTEVES, M., KRAMM, C., CHASE, M., EFIRD, J.T., WEI, M.X., and BREAKEFIELD, X.O. (1994). Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res. 54, 5754-5751.
3. BREAKEFIELD, X.O., and DELUCA, N.A. (1991). Herpes simplex virus for gene delivery to neurons. New Biol. 3, 203-218.
4. BREAKEFIELD, X.O., KRAMM, C.M., CHIOCCA, E.A., and PECHAN, P.A. (1995). Herpes simplex virus vectors for tumor therapy. In The Internet Book of Gene Therapy. Cancer Therapeutics. R.E. Sobol and K.J. Scanlon, eds. (Appleton & Lange, Stamford, CT) pp. 41-56.
5. DELUCA, N.A., and SCHAFFER, P.A. (1987). Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res. 15, 4491-4511.
6. DELUCA, N.A., MCCARTHY, A.M., and SCHAFFER, P.A. (1985). Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56, 558-570.
7. c-DR1 region is required for high-level a-sequence-mediated recombination. J. Virol. 68, 3733-3741.
8. FEDEROFF, H.J., GERSCHWIND, M.D., GELLER, A.I., and KESSLER, J.A. (1992). Expression of nerve growth factor in vivo from a defective HSV-1 vector prevents effects of axotomy on sympathetic ganglia. Proc. Natl. Acad. Sci. USA 89, 1636-1640.
9. FEINBERG, A., and VOGELSTEIN, B. (1983). A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13.
10. FIELD, H.J., and WILDY, P. (1978). The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J. Hygiene 81, 267-277.
11. FRENKEL, N. (1981). Defective interfering herpesviruses. In The Human Herpesviruses. An Interdisciplinary Prospective. A.J. Nahmias, W.R. Dowdle, and R.S. Schinazy, eds. (Elsevier/North-Holland) pp. 91-120.
12. GELLER, A.I., and BREAKEHELD, X.O. (1988). A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science 241, 1667-1669.
13. GELLER, A.I., DURING, M.J., HAYCOCK, J.W., FREESE, A., and NEVE, R. (1993). Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector. Proc. Natl. Acad. Sci. USA 90, 7603-7607.
14. GLORIOSO, J.C., BENDER, M.A., GOINS, W.F., FINK, D.J., and DELUCA, N.A. (1995). Herpes simplex virus as a gene-delivery vector for the central nervous system. In Viral Vectors. Gene Therapy and Neuroscience Applications. M.G. Kaplitt and A.D. Loewy, eds. (Academic Press, San Diego) pp. 1-23.
15. GOLDSTEIN, D.J., and WELLER, S.K. (1988). Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant. J. Virol. 62, 196-205.
16. HENSON, J.W. (1994). Regulation of the glial-specific JC virus early promoter by the transcription factor Sp1. J. Biol. Chem. 269, 1046-1050.
17. HO, D.Y. (1994). Amplicon-based herpes simplex vectors. Methods Cell. Biol. 43, 191-210.
18. HONESS, R.W., and ROIZMAN, B. (1974). Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14, 8-19.
19. JAMIESON, A.T., GENTRY, G.A., and SUBAK-SHARPE, J.H. (1974). Induction of both thymidine and deoxycytidine kinase activity by herpes virus. J. Gen. Virol. 24, 465-480.
20. JOHNSON, P.A., and FRIEDMANN, T. (1994). Replication-defective recombinant herpes simplex virus vectors. Methods Cell. Biol. 43, 211-230.
21. JOHNSON, P.A., BEST, M.G., FRIEDMANN, T., and PARRIS, D.W. (1991). Isolation of a herpes simplex virus type 1 mutant deleted for the essential UL42 gene and characterization of its null phenotype. J. Virol. 65, 700-710.
22. JOHNSON, P.A., MIYANOHARA, A., LEVINE, F., CAHILL, T., and FRIEDMANN, T. (1992). Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J. Virol. 66, 2952-2965.
23. KAPLITT, M.G., PFAUS, J.G., KLEOPOULOS, S.P., HANLON, B.A., RABKIN, S.D., and PFAFF, D.W. (1991). Expression of a functional foreign gene in adult mammalian brain following in vivo transfer via a herpes simplex type 1 defective viral vector. Mol. Cell. Neurosci. 2, 320-330.
24. KENNY, S., NATARAJAN, V., STRIKE, D., KHOURY, G., and SALZMAN, N.P. (1984). JC virus enhancer-promoter active in human brain cells. Science 226, 1337-1339.
25. KRAMM, C.M., SENA-ESTEVES, M., BARNETT, F., RAINOV, N., SCHUBACK, D., YU, J., PECHAN, P.A., PAULUS, W., CHIOCCA, E.A., and BREAKEFIELD, X.O. (1995). Gene therapy for brain tumors. Brain Pathol. 5, 345-381.
26. KWONG, A.D., and FRENKEL, N. (1985). The herpes simplex virus amplicon. IV. Efficient expression of a chimeric chicken ovalbumin gene amplified within defective virus genomes. Virology 142, 421-425.
27. KWONG, A.D., and FRENKEL, N. (1995). Biology of herpes simplex virus (HSV) defective viruses and development of the amplicon system. In Viral vectors. Gene Therapy and Neuroscience Applications. M.G. Kaplitt and A.D. Loewy, eds. (Academic Press) pp. 25-43.
28. LEIB, D.A., and OLIVO, P.D. (1993). Gene delivery to neurons: Is herpes simplex virus the right tool for the job? BioEssays 15, 547-554.
29. LOWENSTEIN, P.R., FOURNEL, S., BAIN, D., CLISSOLD, P.M., CASTRO, M.G., and EPSTEIN, A.L. (1994). Herpes simplex virus 1 (HSV-1) helper co-infection affects the distribution of an amplicon encoded protein in glia. Neuroreport 5, 1625-1630.
30. LOWENSTEIN, P.R., FOURNEL, S., BAIN, D., CLISSOLD, P.M., CASTRO, M.G., and EPSTEIN, A.L. (1995). Simultaneous detection of amplicon and HSV-1 helper encoded proteins reveals that neurons and astrocytoma cells do express amplicon-borne transgenes in the absence of synthesis of virus immediate early proteins. Mol. Brain. Res. 30, 169-175.
31. MACKEM, S., and ROIZMAN, B. (1982). Structural features of the herpes simplex virus alpha gene 4, 0, and 27 promoter regulatory sequences which confer alpha regulation on chimeric thymidine kinase genes. J. Virol. 44, 939-949.
32. MARTUZA, R.L., MALICK, A., MARKERT, J.M., RUFFNER, K.L., and COEN, D.M. (1991). Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252, 854-856.
33. PECHAN, P., CHIOCCA, E.A., CHASE, M., THOMPSON, R.L., COREY, D.P., and BREAKEFIELD, X.O. (1994). A novel herpes simplex virus 'piggyback' packaging system for amplicon vectors. Soc. Neurosci. Abstr. 20, 731.3.
34. PRESTON, V.G., DAVISON, A.J., MARSDEN, H.S., TIMBURY, M.C., SUBAKSHARPE, J.H., and WILKIE, N.M. (1978). Recombinants between herpes simplex virus types 1 and 2; analysis of genome structures and expression of immediate early polypeptides. J. Virol. 28, 499-517.
35. PRICE, J., TURNER, D., and CEPKO, C. (1987). Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 84, 156-160.
36. RICE, S.A., and KNIPE, D.M. (1990). Genetic evidence for two distinct transactivation functions of the herpes simplex virus - protein ICP27. J. Virol. 64, 1704-1715.
37. SAMANIEGO, L.A., WEBB, A.L., and DELUCA, N.A. (1995). Functional interactions between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4. J. Virol. 69, 5705-5715.
38. SANGER, F., NICKLEN, S., and COULSON, A. (1977). DNA sequencing with chainterminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
39. SPAETE, R.R., and FRENKEL, N. (1982). The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell 30, 295-304.